[Usefulness of antineutrophil cytoplamic antibodies in giant cell arteritis]

H Gil1, F Mauny, N Meaux-Ruault

  • 1Service de médecine interne, CHU Jean-Minjoz, Besançon, France. hgil@chu-besancon.fr

La Revue De Medecine Interne
|March 29, 2008
PubMed

Insights

Antineutrophil cytoplasmic antibody (ANCA) detection in giant cell arteritis patients may predict earlier relapse. ANCA-positive individuals require closer monitoring for timely intervention.

Area of Science:

  • Rheumatology
  • Immunology

Context:

  • Giant cell arteritis (GCA) is a systemic vasculitis.
  • The role of antineutrophil cytoplasmic antibodies (ANCA) in GCA pathogenesis and clinical course remains unclear.

Purpose:

  • To determine the frequency of ANCA in patients with giant cell arteritis.
  • To evaluate the impact of ANCA on the disease course and relapse patterns in GCA.

Summary:

  • Thirty GCA patients were assessed for ANCA.
  • ANCA positivity was observed in 30% of patients.
  • No significant differences in clinical/biological data or relapse numbers were found between ANCA-positive and ANCA-negative groups, but relapses occurred significantly earlier in ANCA-positive patients (6 vs. 31.5 months).

Impact:

  • ANCA detection in GCA may indicate an increased risk of premature relapse.
  • This finding suggests that ANCA-positive GCA patients may benefit from intensified monitoring and prompt management strategies.
Abstract